Clinical Trial Update: Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens [Phase 2]

View source ↗

Summary

Phase 2 trial of nivolumab in advanced or metastatic squamous cell non-small cell lung cancer after at least 2 prior regimens completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Squamous Cell Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-10-22